ANTX vs ICE · $32.0M cap vs P/E 37, rev $7.28B
AN2 Therapeutics Inc (ANTX) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
ANTX does not have a complete income-statement cache yet.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ANTX currently screens at market cap $32.0M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ANTX and ICE stock pages for the full models.
Not investment advice.